2 years or older:
-Suspension: Instill 1 to 2 drops into the conjunctival sac of the affected eye(s) up to 4 to 6 times a day; in severe disease, may be used hourly and tapered to discontinuation as inflammation subsides
-A maximum of 20 mL of suspension should be prescribed initially and should not be refilled without further evaluation of the patient's condition.
-If signs/symptoms fail to improve after 2 days of treatment, the patient should be re-evaluated.
-For the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or risk of bacterial ocular infection exists
-Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation; also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns; or penetration of foreign bodies
-The anti-infective component of this drug is active against the following common bacterial eye pathogens: Staphylococcus aureus, Escherichia coli, Haemophilus influenzae, Klebsiella/Enterobacter species, Neisseria species, and Pseudomonas aeruginosa; this drug does not provide adequate coverage against Serratia marcescens and Streptococci including S pneumoniae